PIGL promotes the docetaxel resistance of prostate cancer and is regulated by E3 ubiquitin ligase HUWE1 - Top-Institutions - MDSpire

PIGL promotes the docetaxel resistance of prostate cancer and is regulated by E3 ubiquitin ligase HUWE1

  • By

  • Pan Gao

  • Bo-Han Lin

  • Zhi Zhang

  • Ze-Yu Yi

  • Zhi-Bin Ke

  • Zhong-Hua Zhu

  • Zhen Kang

  • Yong Wei

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Gustave Roussy
    Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #2

    Centre Oscar Lambret
    Centre Oscar Lambret

    Lille, Hauts-de-France

    Key Differentiators

    • Oncology

  • #3

    University of Paris Saclay
    University of Paris Saclay

    Paris, Île-de-France

    Key Differentiators

    • Oncology

  • #4

    First Affiliated Hospital of Fujian Medical University
    First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian

    Key Differentiators

    • Oncology

  • #5

    Second People’s Hospital of Yichang
    Second People’s Hospital of Yichang

    Yichang, Hubei

    Key Differentiators

    • Oncology

Original Source(s)

PIGL promotes the docetaxel resistance of prostate cancer and is regulated by E3 ubiquitin ligase HUWE1

  • by Pan Gao, Bo-Han Lin, Zhi Zhang, Ze-Yu Yi, Zhi-Bin Ke, Zhong-Hua Zhu, Zhen Kang, Yong Wei

  • June 18, 2026

Related Content

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study

HuBIE: The human blood immunome encyclopedia of TCRs and BCRs in bloodstream infections and cancer

The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells